October 03, 2026 06:33 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
‘Hanuman Chalisa gave me courage’: Smit Machchhar recounts flydubai cockpit battle to PM Modi | PM Modi speaks to Flydubai pilot Smit Machchhar who foiled crash plot, praises his courage | Putin praises Modi’s ‘good ideas’ to end Ukraine war, thanks Indian PM for peace efforts | Flydubai cockpit attack: Injured Indian pilot Smit Machchhar airlifted to Abu Dhabi | India backs brave flydubai pilot Smit Machchhar, Ambassador meets family after cockpit attack | ‘Saved us from a 9/11’: PM Modi praises Captain Smit Machchhar after terrifying flydubai cockpit attack | 'India is proud': PM Modi hails Flydubai Captain Smit Machchhar as ‘hero’ after mid-air cockpit horror | ‘Too early to say’: Benjamin Netanyahu on Iran link to flydubai plane incident | ‘I didn’t wait, I ran’: Israeli dentist reveals how he saved wounded Flydubai captain during cockpit attack | Israel-bound flight lands in Saudi Arabia as pilots fight in cockpit, stabbing triggers hijack scare mid-air
Chinese vaccine
Image: Unsplash

Pakistan says China's Sinopharm vaccine not recommended for people aged above 60

| @indiablooms | Feb 11, 2021, at 04:56 pm

The Chinese Sinopharm vaccine for Covid-19, which started being administered in Pakistan recently, is not recommended for people aged over 60, a top official said.

Speaking to reporters in Islamabad, Special Assistant to the Prime Minister on Health Dr Faisal Sultan was quoted as saying by Dawn News that the government's expert committee while considering the preliminary analysis of Sinopharm data had recommended that the vaccine be licensed for people aged 18-60 "at this stage".

"At this stage, the [committee] did not authorise the vaccine for people older than 60," he added.

When contacted by Dawn News about which vaccine would be used for people over 60 instead of Sinopharm's, Dr Sultan said the AstraZeneca vaccine would be used.

"When our Pakistani experts looked at the data, they were reasonably satisfied with the AstraZeneca data but felt that [based] on the presently available numbers for Sinopharm, the data did not justify its usage for those aged over 60," he said.

"The Chinese have also reiterated this restriction," he added.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.